Metformin alleviates colitis-associated colorectal cancer via inhibition of the TLR4/MyD88/NFκB/MAPK pathway and macrophage M2 polarization
Xueying Lai, Bin Liu, Yu Wan, Ping Zhou, Wanjun Li, Wei Hu, Wei Gong
Topics & Concepts
MetforminTLR4Colorectal cancerMacrophage polarizationMAPK/ERK pathwayNF-κBColitisCancer researchMedicineSignal transductionChemistryInflammationInternal medicineMacrophageEndocrinologyCancerBiochemistryDiabetes mellitusIn vitroMetabolism, Diabetes, and CancerImmune cells in cancerAdipokines, Inflammation, and Metabolic Diseases